...Charles River acquired CRO Oncotest for EUR34 million ($36.1 million) in cash. Oncotest is eligible for...
...payment. Charles River declined to provide further details, and Oncotest did not respond to inquiries. Oncotest GmbH...

...Debiopharm and Oncotest announced that they had identified several predictive biomarker candidates, including a gene signature...
...undisclosed compound from Debiopharm and Oncotest's 3D assay system for patient-derived tumor xenografts correlated with Oncotest's...
...genomic and transcriptomics data. The companies declined to disclose details. Debiopharm Group , Lausanne, Switzerland Oncotest GmbH...

...is provided in Israel via Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA, Petah Tikva, Israel) group member Oncotest...

...Chem.; published online March 20, 2009; doi:10.1021/jm800988r Contact: Thomas Beckers, Nycomed GmbH, Konstanz, Germany e-mail: Thomas.Beckers@oncotest.de...